Inhaled nitric oxide and sildenafil therapy for a pediatric patient with multiple pulmonary arteriovenous malformations

Julie Pantaleoni; Kourosh Parsapour; Alexander A. Kon

doi:10.3233/PIC-13065

Journal of Pediatric Intensive Care, Table of Contents

J Pediatr Intensive Care 2013; 02(04): 181-185
DOI: 10.3233/PIC-13065

Case Report

Georg Thieme Verlag KG Stuttgart – New York

Inhaled nitric oxide and sildenafil therapy for a pediatric patient with multiple pulmonary arteriovenous malformations

Julie Pantaleoni

^aDepartment of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA

,

Kourosh Parsapour

^bDepartment of Pediatric Critical Care Medicine University of California, Irvine School of Medicine, Irvine, CA, USA

,

Alexander A. Kon

^cPediatric Intensive Care Unit, Naval Medical Center San Diego and University of California, San Diego School of Medicine, San Diego, CA, USA

› Author Affiliations
Subject Editor:

Abstract

PDF Download

Abstract

Pulmonary arteriovenous malformations may result in intrapulmonary shunting and hypoxemia, and often are treated by embolization or surgical resection. Previous reports have demonstrated effective treatment of hypoxia with inhaled nitric oxide in the acute setting. In this report, we describe a child with severe hypoxemia secondary to an inoperable pulmonary arteriovenous malformation that was initially managed with the use of nitric oxide followed by long term management with the phosphodiesterase-5 inhibitor, sildenafil.

Keywords

Arteriovenous malformations - nitric oxide - phosphodiesterase-5 inhibitors

PDF (55 kb)